T1	PROC 46 64	Estudio de Fase II
T2	CHEM 81 89	Olaparib
#1	AnnotatorNotes T2	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T3	PROC 112 123	tratamiento
#2	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	PROC 174 184	castración
#3	AnnotatorNotes T4	C0007344; Castration; Therapeutic or Preventive Procedure
T5	PROC 207 291	Estudio multicéntrico de fase II, aleatorizado, doble ciego y controlado con placebo
T6	PROC 297 350	comparar la eficacia, la seguridad y la tolerabilidad
T7	CHEM 355 363	olaparib
#4	AnnotatorNotes T7	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T8	PROC 373 380	placebo
#5	AnnotatorNotes T8	C0032042; Placebos; Therapeutic or Preventive Procedure
T9	PROC 412 423	tratamiento
#6	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 456 486	cáncer de próstata metastásico
T11	DISO 589 607	Cancer de próstata
#7	AnnotatorNotes T11	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T12	PROC 503 513	castración
#8	AnnotatorNotes T12	C0007344; Castration; Therapeutic or Preventive Procedure
T13	PROC 531 544	quimioterapia
#9	AnnotatorNotes T13	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T14	CHEM 556 565	docetaxel
#10	AnnotatorNotes T14	C0246415; docetaxel; Organic Chemical · Pharmacologic Substance
T15	ANAT 599 607	próstata
#11	AnnotatorNotes T15	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T16	ANAT 653 661	próstata
#12	AnnotatorNotes T16	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T17	PROC 690 700	castración
#13	AnnotatorNotes T17	C0007344; Castration; Therapeutic or Preventive Procedure
T18	ANAT 137 145	prostata
#14	AnnotatorNotes T18	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T19	DISO 643 673	Cancer de próstata metastásico
T20	CHEM 427 438	abiraterona
#15	AnnotatorNotes T20	C0754011; abiraterone; Organic Chemical · Pharmacologic Substance
T21	ANAT 466 474	próstata
#16	AnnotatorNotes T21	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T22	CHEM 94 105	Abiraterone
#17	AnnotatorNotes T22	C0754011; abiraterone; Organic Chemical · Pharmacologic Substance
T23	DISO 127 157	cancer de prostata matastásico
T24	Date 13 17	2013
T25	LIVB 442 451	pacientes
#18	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
A1	Status T13 History_of
A2	Status T14 History_of
#19	AnnotatorNotes T1	C0282460; Phase 2 Clinical Trials; Research Activity
#20	AnnotatorNotes T5	C0282460; Phase 2 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#21	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#22	AnnotatorNotes T23	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#23	AnnotatorNotes T10	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#24	AnnotatorNotes T19	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
R1	Combined_with Arg1:T2 Arg2:T22	
R2	Used_for Arg1:T2 Arg2:T3	
R3	Location_of Arg1:T18 Arg2:T23	
R4	Combined_with Arg1:T7 Arg2:T9	
R5	Used_for Arg1:T20 Arg2:T9	
R6	Combined_with Arg1:T8 Arg2:T9	
R7	Experiences Arg1:T25 Arg2:T9	
R8	Experiences Arg1:T25 Arg2:T7	
R9	Experiences Arg1:T25 Arg2:T10	
R10	Location_of Arg1:T21 Arg2:T10	
T26	Observation 158 184	resistente a la castración
R11	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T26	
T27	Observation 487 513	resistente a la castración
R12	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T27	
R13	Experiences Arg1:T25 Arg2:T13	
R14	Used_for Arg1:T14 Arg2:T13	
T28	Quantifier_or_Qualifier 608 616	avanzado
R15	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T28	
T29	Observation 674 700	resistente a la castración
R16	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T29	
R17	Location_of Arg1:T16 Arg2:T19	
R18	Location_of Arg1:T15 Arg2:T11	
R19	Before Arg1:T13 Arg2:T9	
R20	Before Arg1:T4 Arg2:T3	
R21	Experiences Arg1:T25 Arg2:T12	
R22	Before Arg1:T12 Arg2:T9	
#25	AnnotatorNotes T26	C4329620; Castration Resistance; Finding
#26	AnnotatorNotes T27	C4329620; Castration Resistance; Finding
#27	AnnotatorNotes T29	C4329620; Castration Resistance; Finding
R23	Experiences Arg1:T25 Arg2:T8	
R24	Experiences Arg1:T25 Arg2:T27	
#28	AnnotatorNotes T28	C0205179; Advanced phase; Qualitative Concept
A3	Experiencer T25 Patient
